Cardiovascular Disease Clinical Trial
— CAROTFoodsOfficial title:
Bioavailability of Carotenoids Incorporated Into Processed Foods: Bread and Mayonnaise
Verified date | March 2016 |
Source | University of Aberdeen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Carotenoids are a family of pigments found abundantly in fruits and vegetables. They are
responsible for the colour of many fruits and vegetables such as tomatoes, melon, peppers
and orange coloured fruits and vegetables. Carotenoids such as beta-carotene are important
for the human body as precursors of vitamin A. They are also thought to be important as
anti-oxidants and may help protect against cancer and heart disease. Although many foods are
rich sources of carotenoids poor bioavailability often limits the amounts that are absorbed
and available for metabolism in humans.
Devising practical ways and means of increasing carotenoid bioavailability could lead to
better health outcomes. Processed foods are now widely eaten by many, both for their taste
and convenience. No studies have thus far looked at the bioavailability of carotenoids that
have been added into processed foods. Thus the purpose of this study is to investigate the
bioavailability of carotenoids that have been incorporated into processed food products
(bread and mayonnaise).
Status | Completed |
Enrollment | 20 |
Est. completion date | July 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Healthy males and females Aged between 18 and 75 years. Body mass index between 18.5 - 40 kg/m2. Blood pressure equal to or less than 139/89 mmHG. HbA1C less than or equal to 6.5%. Total blood cholesterol less than 6.0mmol/l Exclusion Criteria: - Suffering from Diabetes, kidney disease, hepatic disease, gout, gastrointestinal disorder, thromboembolic or coagulation disease, hypertension, thyroid disorder or hypercholesterolaemia On prescription medications Orlistat, Digoxin, Anti-arrhythmics, tricyclic anti-depressants, neuroleptics, oral anti-diabetic medication, insulin, anti-inflammatories, anti-pyretics and Statins Allergic/Intolerant to any of the foods in the study Vegetarian or Vegan Restricted eating and/or eating disorders Alcohol and/or substance abuse Regularly take nutritional supplements (once a day) Smoking Poor venous access and veins difficult to cannulate |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Rowett Institute of Nutrition and Health, Human Nutrition Unit | Aberdeen |
Lead Sponsor | Collaborator |
---|---|
University of Aberdeen |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Measurement of plasma retinol and retinyl ester concentrations | Plasma retinol and retinyl ester concentrations will be measured using reverse-phase HPLC | at baseline and at every hour for up to 8 hours post-prandial and at 24 hours after the test meal | |
Other | Plasma cholesterol concentrations | Plasma cholesterol concentrations will be measured using reverse-phase HPLC | At baseline and at every hour for up to 8 hours post-prandial and at 24hours after the test meal | |
Other | Satiety and palatability of test meals | Measured using 100mm continuous-line visual analogue scales anchored at each end with opposing answers to satiety and palatability related questions | immediately before and after consumption of test meals | |
Primary | Change in Carotenoid concentrations in plasma and in chylomicron-rich fraction | Carotenoids in plasma and in the chylomicron-rich fraction will be measured using reverse-phase HPLC | At baseline, at every hour for up to 8 hours postprandial and at 24hours after test meal | |
Secondary | Change in carotenoid concentration in urine | Carotenoids in urine will be measured using reverse-phase HPLC | at baseline and at every hour for up to 8 hours post-prandial and at 24hours after test meal |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT02502812 -
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04216342 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03654313 -
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
|
Phase 1 | |
Completed |
NCT03646656 -
Heart Health Buddies: Peer Support to Decrease CVD Risk
|
N/A | |
Completed |
NCT02081066 -
Identification of CETP as a Marker of Atherosclerosis
|
N/A | |
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
Recruiting |
NCT03095261 -
Incentives in Cardiac Rehabilitation
|
N/A | |
Completed |
NCT02868710 -
Individual Variability to Aerobic Exercise Training
|
N/A | |
Not yet recruiting |
NCT02578355 -
National Plaque Registry and Database
|
N/A | |
Completed |
NCT02711878 -
Healing Hearts and Mending Minds in Older Adults Living With HIV
|
N/A | |
Completed |
NCT02589769 -
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
|
N/A | |
Completed |
NCT02998918 -
Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
|
N/A | |
Recruiting |
NCT02885792 -
Coronary Artery Disease in Patients Suffering From Schizophrenia
|
N/A | |
Completed |
NCT02272946 -
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
|
Phase 2 | |
Completed |
NCT02640859 -
Investigation of Metabolic Risk in Korean Adults
|
||
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Completed |
NCT02657382 -
Mental Stress Ischemia: Biofeedback Study
|
N/A | |
Recruiting |
NCT02265250 -
Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
|